| abstract |
Use of a compound selected from: pyridoxal-5'-phosphate, pyridoxal, pyridoxamine, 3-acylated pyridoxal analogues, pharmaceutically acceptable acid addition salts thereof, and mixtures thereof, in the preparation of a medicament for the treatment of cardiovascular and related diseases in a mammal undergoing concurrent treatment with an angiotensin II receptor antagonist. The cardiovascular and related diseases include ischemia, congestive heart failure, hypertrophy, ischemia reperfusion injury, and myocardial ischemia reperfusion injury. |